Cargando…

Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia

OBJECTIVES: To compare the effectiveness of dienogest (DIE) and norethisterone acetate (NETA) regimens in the treatment of endometrial hyperplasia (EH) without atypia. METHODS: Participants were premenopausal women with irregular uterine bleeding, and endometrial hyperplasia without atypia on endome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Girbash, Ehab F., Sherif, Hala E., Radwan, Ahmed M., Abdeldayem, Hussein M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Gynecologic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348941/ https://www.ncbi.nlm.nih.gov/pubmed/37010614 http://dx.doi.org/10.1007/s00404-023-07015-7

Ejemplares similares

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study
por: Del Forno, Simona, et al.
Publicado: (2023)

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
por: Ga, Hiromi, et al.
Publicado: (2023)

Norethisterone-Induced Liver Injury and a Short Survey Among Gynecologists
por: Rather, Jawad Iqbal, et al.
Publicado: (2023)

Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
por: Girbash, Ehab F., et al.
Publicado: (2023)

The value of MRI in management of endometrial hyperplasia with atypia
por: Natarajan, Purushothaman, et al.
Publicado: (2020)

Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Wu, Pengfei, et al.
Publicado: (2022)

Quality of life and clinical factors in women with endometriosis, the role of dienogest vs EE/dienogest over time: a single-center study
por: Maiorana, Antonio, et al.
Publicado: (2023)

Efficacy of Dienogest in Adolescent Endometriosis: A Narrative Review
por: Tayade, Surekha, et al.
Publicado: (2023)

MicroRNAs as Predictors of Future Uterine Malignancy in Endometrial Hyperplasia without Atypia
por: Lin, Chiao-Yun, et al.
Publicado: (2022)

Effects of Dienogest Therapy on Endometriosis-Related Dysmenorrhea, Dyspareunia, and Endometrioma Size
por: Saglik Gokmen, Bilgehan, et al.
Publicado: (2023)

Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment
por: Petraglia, Felice, et al.
Publicado: (2011)

Abdominal Supracervical Hysterectomy With Bilateral Salpingo-Oophorectomy as the Surgical Approach for a 22-Week Uterus With Incidental Endometrial Polyp Focal Atypia
por: Herrera Rodriguez, Maria G, et al.
Publicado: (2020)

Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia
por: Shen, Ye, et al.
Publicado: (2022)

Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma
por: Fujiwara, Kazuko, et al.
Publicado: (2011)

Prostatic Stromal Hyperplasia with Atypia
por: Hutchinson, Ryan C., et al.
Publicado: (2013)

Membrane expression of TRAIL receptors DR4, DR5, DcR1 and DcR2 in the normal endometrium, atypical endometrial hyperplasia and endometrioid adenocarcinoma: a tissue microarray study
por: Gottwald, Leszek, et al.
Publicado: (2013)

A Randomized Clinical Trial of Levonorgestrel Intrauterine System with or without Metformin for Treatment of Endometrial Hyperplasia without Atypia in Indian Women
por: Dinnekere Ravi, Ramya, et al.
Publicado: (2021)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
por: Hui, Lee Shi, et al.
Publicado: (2021)

Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis
por: Zhang, Yu-Fei, et al.
Publicado: (2023)

CD44 expression in curettage and postoperative specimens of endometrial cancer
por: Wojciechowski, Michał, et al.
Publicado: (2014)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
por: Syed, Yahiya Y.
Publicado: (2022)

The sL1CAM in sera of patients with endometrial and ovarian cancers
por: Wojciechowski, Michał, et al.
Publicado: (2016)

Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer
por: Papadia, Andrea, et al.
Publicado: (2016)

Medical Management of Atypical Endometrial Hyperplasia: Oncological and Reproductive Outcomes at a Tertiary Center in Singapore
por: Lee, Shi Hui, et al.
Publicado: (2023)

Association of polymorphisms in the 5′ untranslated region of RAD51 gene with risk of endometrial cancer in the Polish population
por: Michalska, Magdalena M., et al.
Publicado: (2014)

Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab
por: Makker, Vicky, et al.
Publicado: (2021)

Learning curve for laparoscopic staging of early and locally advanced cervical and endometrial cancer
por: Tahmasbi Rad, Morva, et al.
Publicado: (2013)

An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer
por: Mathews, Cara, et al.
Publicado: (2022)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer
por: Cornali, Tommaso, et al.
Publicado: (2017)

A retrospective validation study of sentinel lymph node mapping for high-risk endometrial cancer
por: Wang, Tian, et al.
Publicado: (2019)

The Primodos components Norethisterone acetate and Ethinyl estradiol induce developmental abnormalities in zebrafish embryos
por: Brown, Samantha, et al.
Publicado: (2018)

Correction: Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
por: Syed, Yahiya Y.
Publicado: (2022)

Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer
por: Cabrera, Silvia, et al.
Publicado: (2023)

Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer
por: Siegenthaler, Franziska, et al.
Publicado: (2022)

Clinicopathological and molecular markers associated with prognosis and treatment effectiveness of endometrial stromal sarcoma: a retrospective study in China
por: He, Li, et al.
Publicado: (2013)

Patient-initiated follow-up of early endometrial cancer: a potential to improve post-treatment cardiovascular risk?
por: Johnson, Racheal Louise, et al.
Publicado: (2021)

Fertility preserving management of early endometrial cancer in a patient cohort at the department of women’s health at the university of Tuebingen
por: Andress, Jürgen, et al.
Publicado: (2021)

Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis
por: Travaglino, Antonio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q5aq6ddt4slm55ahvs34vbje59